BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 27039769)

  • 1. Inhibitory Effects of Gallic Acid Isolated from Caesalpinia mimosoides Lamk on Cholangiocarcinoma Cell Lines and Foodborne Pathogenic Bacteria.
    Rattanata N; Klaynongsruang S; Daduang S; Tavichakorntrakool R; Limpaiboon T; Lekphrom R; Boonsiri P; Daduang J
    Asian Pac J Cancer Prev; 2016; 17(3):1341-5. PubMed ID: 27039769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effects of Phytophenolics from Caesalpinia mimosoides Lamk on cervical carcinoma cell lines through an apoptotic pathway.
    Palasap A; Limpaiboon T; Boonsiri P; Thapphasaraphong S; Daduang S; Suwannalert P; Daduang J
    Asian Pac J Cancer Prev; 2014; 15(1):449-54. PubMed ID: 24528072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of compounds isolated from Caesalpinia coriaria (Jacq) Willd against important bacteria in public health.
    Olmedo-Juárez A; Briones-Robles TI; Zaragoza-Bastida A; Zamilpa A; Ojeda-Ramírez D; Mendoza de Gives P; Olivares-Pérez J; Rivero-Perez N
    Microb Pathog; 2019 Nov; 136():103660. PubMed ID: 31398533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticancer effects of Resina Draconis extract on cholangiocarcinoma.
    Wen F; Zhao X; Zhao Y; Lu Z; Guo Q
    Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scabraside D Extracted from Holothuria scabra Induces Apoptosis and Inhibits Growth of Human Cholangiocarcinoma Xenografts in Mice.
    Assawasuparerk K; Vanichviriyakit R; Chotwiwatthanakun C; Nobsathian S; Rawangchue T; Wittayachumnankul B
    Asian Pac J Cancer Prev; 2016; 17(2):511-7. PubMed ID: 26925636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenolic Compounds Isolated from Caesalpinia coriaria Induce S and G2/M Phase Cell Cycle Arrest Differentially and Trigger Cell Death by Interfering with Microtubule Dynamics in Cancer Cell Lines.
    Sánchez-Carranza JN; Alvarez L; Marquina-Bahena S; Salas-Vidal E; Cuevas V; Jiménez EW; Veloz G RA; Carraz M; González-Maya L
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28441723
    [No Abstract]   [Full Text] [Related]  

  • 7. Gold Nanoparticles Enhance the Anticancer Activity of Gallic Acid against Cholangiocarcinoma Cell Lines.
    Rattanata N; Daduang S; Wongwattanakul M; Leelayuwat C; Limpaiboon T; Lekphrom R; Sandee A; Boonsiri P; Chio-Srichan S; Daduang J
    Asian Pac J Cancer Prev; 2015; 16(16):7143-7. PubMed ID: 26514503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylases and their inhibitors as potential therapeutic drugs for cholangiocarcinoma - cell line findings.
    Sriraksa R; Limpaiboon T
    Asian Pac J Cancer Prev; 2013; 14(4):2503-8. PubMed ID: 23725164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid.
    Romani AA; Desenzani S; Morganti MM; Baroni MC; Borghetti AF; Soliani P
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):557-67. PubMed ID: 20473610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological activity of Kaempferia parviflora extract against human bile duct cancer cell lines.
    Leardkamolkarn V; Tiamyuyen S; Sripanidkulchai BO
    Asian Pac J Cancer Prev; 2009; 10(4):695-8. PubMed ID: 19827897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin arrests cell cycling, induces apoptosis and inhibits the JAK/STAT3 pathway in human cholangiocarcinoma cells.
    Aneknan P; Kukongviriyapan V; Prawan A; Kongpetch S; Sripa B; Senggunprai L
    Asian Pac J Cancer Prev; 2014; 15(12):5071-6. PubMed ID: 24998588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells.
    Okabe H; Beppu T; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Jono H; Ueda M; Shinriki S; Ando Y; Baba H
    Ann Surg Oncol; 2011 Apr; 18(4):1175-84. PubMed ID: 21042948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for hepatocellular carcinoma and cholangiocarcinoma.
    Chung V
    Surg Oncol Clin N Am; 2015 Jan; 24(1):187-98. PubMed ID: 25444475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.
    Shen DY; Kang JH; Song W; Zhang WQ; Li WG; Zhao Y; Chen QX
    Phytother Res; 2011 Oct; 25(10):1519-26. PubMed ID: 21394804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZD1839 (IRESSA) stabilizes p27Kip1 and enhances radiosensitivity in cholangiocarcinoma cell lines.
    Yabuuchi S; Katayose Y; Oda A; Mizuma M; Shirasou S; Sasaki T; Yamamoto K; Oikawa M; Rikiyama T; Onogawa T; Yoshida H; Ohtuska H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2009 Apr; 29(4):1169-80. PubMed ID: 19414361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycoepoxydiene induces apoptosis and inhibits TPA-induced invasion in human cholangiocarcinoma cells via blocking NF-κB pathway.
    Li W; Li M; Su X; Qin L; Miao M; Yu C; Shen Y; Luo Q; Chen Q
    Biochimie; 2014 Jun; 101():183-91. PubMed ID: 24486723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE.
    Wang Z; Tang X; Zhang Y; Qi R; Li Z; Zhang K; Liu Z; Yang X
    Biomed Pharmacother; 2012 Apr; 66(3):161-6. PubMed ID: 22425181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Met targeted therapy of cholangiocarcinoma.
    Socoteanu MP; Mott F; Alpini G; Frankel AE
    World J Gastroenterol; 2008 May; 14(19):2990-4. PubMed ID: 18494048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patients.
    Cheng CT; Chen YY; Wu RC; Tsai CY; Chiang KC; Yeh TS; Chen MH; Yeh CN
    Oncol Rep; 2018 Sep; 40(3):1411-1421. PubMed ID: 30015968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.